United Laboratories International Holdings (FRA:UNJ) Inventory-to-Revenue : 0.33 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. United Laboratories International Holdings's Average Total Inventories for the quarter that ended in Dec. 2023 was €285 Mil. United Laboratories International Holdings's Revenue for the six months ended in Dec. 2023 was €878 Mil. United Laboratories International Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.33.

United Laboratories International Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 increased from Jun. 2023 (0.32) to Jun. 2023 (0.33)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. United Laboratories International Holdings's Days Inventory for the six months ended in Dec. 2023 was 109.10.

Inventory Turnover measures how fast the company turns over its inventory within a year. United Laboratories International Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.67.

United Laboratories International Holdings Inventory-to-Revenue Historical Data

The historical data trend for United Laboratories International Holdings's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Inventory-to-Revenue Chart

United Laboratories International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.18

0.17

0.19

0.16

United Laboratories International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															0.36	0.40	0.36	0.32	0.33

Competitive Comparison of United Laboratories International Holdings's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Laboratories International Holdings's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Inventory-to-Revenue falls into.

United Laboratories International Holdings Inventory-to-Revenue Calculation

United Laboratories International Holdings's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (292.965	+	287.483)	/	2 )	/	1764.582
=	290.224					/	1764.582
=	0.16

United Laboratories International Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (282.47	+	287.483)	/	2 )	/	877.593
=	284.9765					/	877.593
=	0.32

United Laboratories International Holdings (FRA:UNJ) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

United Laboratories International Holdings's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	284.9765	/	476.701	*	365 / 2
	=	109.10

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

United Laboratories International Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	476.701	/	284.9765
	=	1.67

United Laboratories International Holdings Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings (FRA:UNJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

ULIHF:USA 03933:Hong Kong UNJ:Germany

Address

No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG

Website

http://www.tul.com.cn

United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines